All currency values in $ millions unless otherwise noted
Scroll
| Income Statement | MAR 2026 | MAR 2025 | MAR 2024 3:1 split | MAR 2023 ~1.5:1 split | MAR 2022 |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue | – | – | – | $0 | – |
| Cost of Revenue | – | – | – | $0 | $1 |
| Gross Profit | – | – | – | -$0 | -$0 |
| Operating Expenses | |||||
| Selling & Marketing | $0 | $0 | $0 | $0 | – |
| General & Administrative | $1 | $1 | $1 | $0 | $0 |
| Research & Development | $0 | – | – | – | – |
| Other Operating Expenses | – | – | – | $0 | $0 |
| Total Operating Expenses | $1 | $2 | $2 | $0 | $1 |
| Operating Income | -$2 | -$1 | -$2 | -$0 | $0 |
| Other Non-Operating Income (Expense) | – | – | -$0 | $0 | – |
| Earnings from Continuing Ops | – | – | – | $0 | $0 |
| Net Income | |||||
| Net Income | -$2 | -$1 | -$2 | -$0 | -$0 |
| Per Share Data | |||||
| Revenue Per Share | – | – | – | $0.01 | – |
| EPS (Basic) | -$0.01 | -$0.01 | -$0.02 | $0.00 | $0.00 |
| EPS (Diluted) | -$0.01 | -$0.01 | -$0.02 | -$0.01 | -$0.00 |
| Weighted Avg Shares (Basic) | 138.0M | 128.1M | 86.5M | 38.5M | 26.3M |
| Shares Outstanding | 153.2M | 137.4M | 117.2M | 38.5M | 26.3M |
Avai Bio (AVAI) financials: revenue, profit and margins
Avai Bio (AVAI) generated about n/a in revenue and -$2 million in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.
Frequently asked
Is Avai Bio profitable?+
Avai Bio reported about -$2 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
SourceFinancial statements computed from the 10-Q filed 13 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 14 Oct 2026. How this is calculated.
Fiscal year ends Mar.
Peers
Services-Computer Processing & Data Preparation · Pick stocks to compare with AVAI
Spot a number that looks wrong? Check it in AVAI's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing AVAI
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.